Completed PHASE2 INTERVENTIONAL 3-arm NCT00295334

Moderate Alcohol Intake Among Patients With Type 2 Diabetes

Sponsor: Hadassah Medical Organization

Interventions alcohol

Updated 7 times since 2017 Last updated: Jun 5, 2025 Started: Jun 30, 2010 Primary completion: May 31, 2012 Completion: May 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00295334, this PHASE2 trial focuses on Type 2 Diabetes and remains completed. Sponsored by Hadassah Medical Organization, it has been updated 7 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Jul 2025 — Present [monthly]

Completed PHASE2

Status: Unknown → Completed
Sep 2024 — Jul 2025 [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Nov 2022 — Jul 2024 [monthly]

Unknown Status PHASE2
Jan 2021 — Nov 2022 [monthly]

Unknown Status PHASE2

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

First recorded

Jun 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hadassah Medical Organization
Harvard University
Iris Shai
Julio Vainstein, Wolfson Medical Center, Holon, Israel
Soroka University Medical Center
The Israeli Diabetes Research Group
Tishbi Wines, Israel and Admiral Wine Imports, US

Data source: The S. Daniel Abraham International Center for Health and Nutrition

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.